Package 63629-4874-1

Brand: ranolazine

Generic: ranolazine
NDC Package

Package Facts

Identity

Package NDC 63629-4874-1
Digits Only 6362948741
Product NDC 63629-4874
Product ID 63629-4874_ef5432b9-f1d1-4166-a264-337420d7ec04
Description

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4874-1)

Marketing

Marketing Status
Marketed Since 2025-01-17
Brand ranolazine
Generic ranolazine
Sample Package No

Linked Drug Pages (1)

Ranolazine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ef5432b9-f1d1-4166-a264-337420d7ec04", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749"], "spl_set_id": ["2e678c80-1410-433b-8c48-4b210eceb0de"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-4874-1)", "package_ndc": "63629-4874-1", "marketing_start_date": "20250117"}], "brand_name": "Ranolazine", "product_id": "63629-4874_ef5432b9-f1d1-4166-a264-337420d7ec04", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "63629-4874", "generic_name": "Ranolazine", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA210188", "marketing_category": "ANDA", "marketing_start_date": "20190910", "listing_expiration_date": "20261231"}